#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Tissue-Specific Effects of Reduced β-catenin Expression on Mutation-Instigated Tumorigenesis in Mouse Colon and Ovarian Epithelium


Enhanced Wnt signaling contributes to colorectal and other cancers. β-catenin functions in Wnt signaling as a T cell factor (TCF) transcriptional co-activator. Previous studies showed specific β-catenin dosage favors Wnt signaling-dependent tumorigenesis for some tumor types. However, earlier studies emphasized the role of constitutional Ctnnb1 and Apc gene variations, rather than somatic gene targeting, and the work focused on small intestine tumors and no effects on colon tumor phenotypes were described. Furthermore, definitive insights were lacking into how reduced Ctnnb1 gene dosage affected Apc mutation-dependent tumorigenesis. Here, we show somatic inactivation of one Ctnnb1 allele dramatically inhibits mouse colon adenomatous polyposis induced by somatic bi-allelic Apc inactivation. In contrast, Ctnnb1 hemizygous inactivation does not affect mouse ovarian endometrioid adenocarcinoma development arising from Apc- and Pten-inactivation. Ctnnb1 hemizygous gene dose dramatically reduces the active pool of β-catenin, leading to the significant inhibition of β-catenin/TCF-regulated target gene expression, including those encoding key stem cell regulatory and crypt compartmentalization factors in colon epithelium. Tissue-specific differences for expression of selected β-catenin/TCF-regulated genes, such as Myc, may contribute to the context-dependent effects of Ctnnb1 gene dosage in Apc mutation-driven colon and ovarian tumors.


Vyšlo v časopise: Tissue-Specific Effects of Reduced β-catenin Expression on Mutation-Instigated Tumorigenesis in Mouse Colon and Ovarian Epithelium. PLoS Genet 11(11): e32767. doi:10.1371/journal.pgen.1005638
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pgen.1005638

Souhrn

Enhanced Wnt signaling contributes to colorectal and other cancers. β-catenin functions in Wnt signaling as a T cell factor (TCF) transcriptional co-activator. Previous studies showed specific β-catenin dosage favors Wnt signaling-dependent tumorigenesis for some tumor types. However, earlier studies emphasized the role of constitutional Ctnnb1 and Apc gene variations, rather than somatic gene targeting, and the work focused on small intestine tumors and no effects on colon tumor phenotypes were described. Furthermore, definitive insights were lacking into how reduced Ctnnb1 gene dosage affected Apc mutation-dependent tumorigenesis. Here, we show somatic inactivation of one Ctnnb1 allele dramatically inhibits mouse colon adenomatous polyposis induced by somatic bi-allelic Apc inactivation. In contrast, Ctnnb1 hemizygous inactivation does not affect mouse ovarian endometrioid adenocarcinoma development arising from Apc- and Pten-inactivation. Ctnnb1 hemizygous gene dose dramatically reduces the active pool of β-catenin, leading to the significant inhibition of β-catenin/TCF-regulated target gene expression, including those encoding key stem cell regulatory and crypt compartmentalization factors in colon epithelium. Tissue-specific differences for expression of selected β-catenin/TCF-regulated genes, such as Myc, may contribute to the context-dependent effects of Ctnnb1 gene dosage in Apc mutation-driven colon and ovarian tumors.


Zdroje

1. Fearon ER. Molecular genetics of colorectal cancer. Annu Rev Pathol. 2011;6:479–507. Epub 2010/11/26. eng. doi: 10.1146/annurev-pathol-011110-130235 21090969

2. Rustgi AK. The genetics of hereditary colon cancer. Genes Dev. 2007;21(20):2525–38. Epub 2007/10/17. eng. 17938238

3. Moser AR, Shoemaker AR, Connelly CS, Clipson L, Gould KA, Luongo C, et al. Homozygosity for the Min allele of Apc results in disruption of mouse development prior to gastrulation. Developmental dynamics: an official publication of the American Association of Anatomists. 1995;203(4):422–33.

4. Aoki K, Taketo MM. Adenomatous polyposis coli (APC): a multi-functional tumor suppressor gene. J Cell Sci. 2007;120(Pt 19):3327–35. Epub 2007/09/21. eng.

5. Brocardo M, Henderson BR. APC shuttling to the membrane, nucleus and beyond. Trends in cell biology. 2008;18(12):587–96. doi: 10.1016/j.tcb.2008.09.002 18848448

6. Polakis P. The many ways of Wnt in cancer. Curr Opin Genet Dev. 2007;17(1):45–51. Epub 2007/01/09. eng. 17208432

7. Mosimann C, Hausmann G, Basler K. Beta-catenin hits chromatin: regulation of Wnt target gene activation. Nature reviews Molecular cell biology. 2009;10(4):276–86. doi: 10.1038/nrm2654 19305417

8. Barker N, van Es JH, Kuipers J, Kujala P, van den Born M, Cozijnsen M, et al. Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature. 2007;449(7165):1003–7. Epub 2007/10/16. eng. 17934449

9. Clevers H, Nusse R. Wnt/beta-catenin signaling and disease. Cell. 2012;149(6):1192–205. Epub 2012/06/12. eng. doi: 10.1016/j.cell.2012.05.012 22682243

10. van de Wetering M, Sancho E, Verweij C, de Lau W, Oving I, Hurlstone A, et al. The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell. 2002;111(2):241–50. Epub 2002/11/01. eng. 12408868

11. Batlle E, Henderson JT, Beghtel H, van den Born MM, Sancho E, Huls G, et al. Beta-catenin and TCF mediate cell positioning in the intestinal epithelium by controlling the expression of EphB/ephrinB. Cell. 2002;111(2):251–63. Epub 2002/11/01. eng. 12408869

12. Sansom OJ, Reed KR, Hayes AJ, Ireland H, Brinkmann H, Newton IP, et al. Loss of Apc in vivo immediately perturbs Wnt signaling, differentiation, and migration. Genes Dev. 2004;18(12):1385–90. Epub 2004/06/17. eng. 15198980

13. Segditsas S, Tomlinson I. Colorectal cancer and genetic alterations in the Wnt pathway. Oncogene. 2006;25(57):7531–7. 17143297

14. Bakker ER, Hoekstra E, Franken PF, Helvensteijn W, van Deurzen CH, van Veelen W, et al. beta-Catenin signaling dosage dictates tissue-specific tumor predisposition in Apc-driven cancer. Oncogene. 2013;32(38):4579–85. doi: 10.1038/onc.2012.449 23045279

15. Buchert M, Athineos D, Abud HE, Burke ZD, Faux MC, Samuel MS, et al. Genetic dissection of differential signaling threshold requirements for the Wnt/beta-catenin pathway in vivo. PLoS genetics. 2010;6(1):e1000816. doi: 10.1371/journal.pgen.1000816 20084116

16. Akyol A, Hinoi T, Feng Y, Bommer GT, Glaser TM, Fearon ER. Generating somatic mosaicism with a Cre recombinase-microsatellite sequence transgene. Nat Methods. 2008;5(3):231–3. Epub 2008/02/12. eng. doi: 10.1038/nmeth.1182 18264107

17. Feng Y, Sentani K, Wiese A, Sands E, Green M, Bommer GT, et al. Sox9 induction, ectopic Paneth cells, and mitotic spindle axis defects in mouse colon adenomatous epithelium arising from conditional biallelic Apc inactivation. The American journal of pathology. 2013;183(2):493–503. doi: 10.1016/j.ajpath.2013.04.013 23769888

18. Sato T, van Es JH, Snippert HJ, Stange DE, Vries RG, van den Born M, et al. Paneth cells constitute the niche for Lgr5 stem cells in intestinal crypts. Nature. 2011;469(7330):415–8. Epub 2010/11/30. eng. doi: 10.1038/nature09637 21113151

19. Andreu P, Colnot S, Godard C, Gad S, Chafey P, Niwa-Kawakita M, et al. Crypt-restricted proliferation and commitment to the Paneth cell lineage following Apc loss in the mouse intestine. Development. 2005;132(6):1443–51. Epub 2005/02/18. eng. 15716339

20. Andreu P, Peignon G, Slomianny C, Taketo MM, Colnot S, Robine S, et al. A genetic study of the role of the Wnt/beta-catenin signalling in Paneth cell differentiation. Dev Biol. 2008;324(2):288–96. Epub 2008/10/25. eng. doi: 10.1016/j.ydbio.2008.09.027 18948094

21. Hirata A, Utikal J, Yamashita S, Aoki H, Watanabe A, Yamamoto T, et al. Dose-dependent roles for canonical Wnt signalling in de novo crypt formation and cell cycle properties of the colonic epithelium. Development. 2013;140(1):66–75. Epub 2012/12/12. eng. doi: 10.1242/dev.084103 23222438

22. Clevers H, Batlle E. EphB/EphrinB receptors and Wnt signaling in colorectal cancer. Cancer research. 2006;66(1):2–5. 16397205

23. Cortina C, Palomo-Ponce S, Iglesias M, Fernandez-Masip JL, Vivancos A, Whissell G, et al. EphB-ephrin-B interactions suppress colorectal cancer progression by compartmentalizing tumor cells. Nature genetics. 2007;39(11):1376–83. 17906625

24. Nishimura S, Wakabayashi N, Toyoda K, Kashima K, Mitsufuji S. Expression of Musashi-1 in human normal colon crypt cells: a possible stem cell marker of human colon epithelium. Dig Dis Sci. 2003;48(8):1523–9. Epub 2003/08/20. eng. 12924647

25. Potten CS, Booth C, Tudor GL, Booth D, Brady G, Hurley P, et al. Identification of a putative intestinal stem cell and early lineage marker; musashi-1. Differentiation. 2003;71(1):28–41. Epub 2003/02/01. eng. 12558601

26. He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, et al. Identification of c-MYC as a target of the APC pathway. Science. 1998;281(5382):1509–12. 9727977

27. Staal FJ, Noort Mv M, Strous GJ, Clevers HC. Wnt signals are transmitted through N-terminally dephosphorylated beta-catenin. EMBO reports. 2002;3(1):63–8. 11751573

28. van Noort M, Meeldijk J, van der Zee R, Destree O, Clevers H. Wnt signaling controls the phosphorylation status of beta-catenin. The Journal of biological chemistry. 2002;277(20):17901–5. 11834740

29. Wu R, Hendrix-Lucas N, Kuick R, Zhai Y, Schwartz DR, Akyol A, et al. Mouse model of human ovarian endometrioid adenocarcinoma based on somatic defects in the Wnt/beta-catenin and PI3K/Pten signaling pathways. Cancer cell. 2007;11(4):321–33. 17418409

30. Moreno-Bueno G, Gamallo C, Perez-Gallego L, de Mora JC, Suarez A, Palacios J. beta-Catenin expression pattern, beta-catenin gene mutations, and microsatellite instability in endometrioid ovarian carcinomas and synchronous endometrial carcinomas. Diagnostic molecular pathology: the American journal of surgical pathology, part B. 2001;10(2):116–22.

31. Sagae S, Kobayashi K, Nishioka Y, Sugimura M, Ishioka S, Nagata M, et al. Mutational analysis of beta-catenin gene in Japanese ovarian carcinomas: frequent mutations in endometrioid carcinomas. Japanese journal of cancer research: Gann. 1999;90(5):510–5. 10391090

32. Wright K, Wilson P, Morland S, Campbell I, Walsh M, Hurst T, et al. beta-catenin mutation and expression analysis in ovarian cancer: exon 3 mutations and nuclear translocation in 16% of endometrioid tumours. International journal of cancer Journal international du cancer. 1999;82(5):625–9. 10417756

33. Wu R, Zhai Y, Fearon ER, Cho KR. Diverse mechanisms of beta-catenin deregulation in ovarian endometrioid adenocarcinomas. Cancer research. 2001;61(22):8247–55. Epub 2001/11/24. eng. 11719457

34. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 1990;61(5):759–67. Epub 1990/06/01. eng. 2188735

35. Kinzler KW, Vogelstein B. Lessons from hereditary colorectal cancer. Cell. 1996;87(2):159–70. Epub 1996/10/18. eng. 8861899

36. Albuquerque C, Breukel C, van der Luijt R, Fidalgo P, Lage P, Slors FJ, et al. The 'just-right' signaling model: APC somatic mutations are selected based on a specific level of activation of the beta-catenin signaling cascade. Human molecular genetics. 2002;11(13):1549–60. 12045208

37. Athineos D, Sansom OJ. Myc heterozygosity attenuates the phenotypes of APC deficiency in the small intestine. Oncogene. 2010;29(17):2585–90. doi: 10.1038/onc.2010.5 20140021

38. Reed KR, Athineos D, Meniel VS, Wilkins JA, Ridgway RA, Burke ZD, et al. B-catenin deficiency, but not Myc deletion, suppresses the immediate phenotypes of APC loss in the liver. Proceedings of the National Academy of Sciences of the United States of America. 2008;105(48):18919–23. doi: 10.1073/pnas.0805778105 19033191

39. Sansom OJ, Meniel VS, Muncan V, Phesse TJ, Wilkins JA, Reed KR, et al. Myc deletion rescues Apc deficiency in the small intestine. Nature. 2007;446(7136):676–9. 17377531

40. Shibata H, Toyama K, Shioya H, Ito M, Hirota M, Hasegawa S, et al. Rapid colorectal adenoma formation initiated by conditional targeting of the Apc gene. Science. 1997;278(5335):120–3. Epub 1997/10/06. eng. 9311916

41. Brault V, Moore R, Kutsch S, Ishibashi M, Rowitch DH, McMahon AP, et al. Inactivation of the beta-catenin gene by Wnt1-Cre-mediated deletion results in dramatic brain malformation and failure of craniofacial development. Development. 2001;128(8):1253–64. Epub 2001/03/23. eng. 11262227

42. Srinivas S, Watanabe T, Lin CS, William CM, Tanabe Y, Jessell TM, et al. Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus. BMC Dev Biol. 2001;1:4. Epub 2001/04/12. eng. 11299042

43. Lustig B, Jerchow B, Sachs M, Weiler S, Pietsch T, Karsten U, et al. Negative feedback loop of Wnt signaling through upregulation of conductin/axin2 in colorectal and liver tumors. Mol Cell Biol. 2002;22(4):1184–93. Epub 2002/01/26. eng. 11809809

44. Roig AI, Eskiocak U, Hight SK, Kim SB, Delgado O, Souza RF, et al. Immortalized epithelial cells derived from human colon biopsies express stem cell markers and differentiate in vitro. Gastroenterology. 2010;138(3):1012–21 e1–5. Epub 2009/12/08. eng. doi: 10.1053/j.gastro.2009.11.052 19962984

45. Feng Y, Bommer GT, Zhai Y, Akyol A, Hinoi T, Winer I, et al. Drosophila split ends homologue SHARP functions as a positive regulator of Wnt/beta-catenin/T-cell factor signaling in neoplastic transformation. Cancer research. 2007;67(2):482–91. Epub 2007/01/20. eng. 17234755

46. Kaneko Y, Sakakibara S, Imai T, Suzuki A, Nakamura Y, Sawamoto K, et al. Musashi1: an evolutionally conserved marker for CNS progenitor cells including neural stem cells. Dev Neurosci. 2000;22(1–2):139–53. Epub 2000/02/05. eng. 10657706

47. Sakakibara S, Imai T, Hamaguchi K, Okabe M, Aruga J, Nakajima K, et al. Mouse-Musashi-1, a neural RNA-binding protein highly enriched in the mammalian CNS stem cell. Dev Biol. 1996;176(2):230–42. Epub 1996/06/15. eng. 8660864

Štítky
Genetika Reprodukčná medicína

Článok vyšiel v časopise

PLOS Genetics


2015 Číslo 11
Najčítanejšie tento týždeň
Najčítanejšie v tomto čísle
Kurzy

Zvýšte si kvalifikáciu online z pohodlia domova

Získaná hemofilie - Povědomí o nemoci a její diagnostika
nový kurz

Eozinofilní granulomatóza s polyangiitidou
Autori: doc. MUDr. Martina Doubková, Ph.D.

Všetky kurzy
Prihlásenie
Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa

#ADS_BOTTOM_SCRIPTS#